HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With CBD Poised To Become A Novel Food In Europe, Industry Must Think Ahead To Gain Advantage

Executive Summary

Europe's dynamic CBD market could soon see tighter regulation, after the European Commission (EC) last month added the ingredient to its Novel Food Catalogue. Regulatory expert Janet Worrell argues that the time is now for CBD industry players to act to get ahead of this potentially transformative development. 

You may also be interested in...



Can Synthetic CBD Overcome Cannabis Stigma And Break EU Novel Foods Deadlock?

Czech firm CBDepot has filed a novel food application for synthetically made CBD in Europe, which it hopes regulators will find more palatable than those for supplements derived from the cannabis plant.

Pain Relief Most Popular Reason For Using CBD In UK

Pain relief is by far the most popular reason for taking CBD in the UK, a recent survey has revealed. The research by YouGov also finds that a quarter of those who have not tried CBD are tempted to do so. 

Germany And Sweden Leading The EU In CBD Enforcement Action

Sweden and Germany are cracking down on unauthorized CBD food products and warning their neighbors of the health risks posed to consumers, an analysis by HBW Insight reveals. A large proportion of these CBD products are being sold as food supplements and many originate from the Netherlands. 

Related Content

Topics

UsernamePublicRestriction

Register

RS148516

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel